Related references
Note: Only part of the references are listed.Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections
S. Mohd Sazlly Lim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The Influence of Normalization Weight in Population Pharmacokinetic Covariate Models
Sebastiaan C. Goulooze et al.
CLINICAL PHARMACOKINETICS (2019)
Fixed-dose combinations: a potential means to boost drug development for selected drugs
Charles Oo et al.
DRUG DISCOVERY TODAY (2018)
Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system
Keith Poole et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China
Tao Li et al.
JOURNAL OF THORACIC DISEASE (2018)
Synergy effect of meropenem- based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
Zhihui Jiang et al.
INFECTION AND DRUG RESISTANCE (2018)
Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study
Demosthenes Makris et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2018)
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
Sebastian G. Wicha et al.
NATURE COMMUNICATIONS (2017)
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients
Abdulaziz S. Alobaid et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients
Abdulaziz S. Alobaid et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii
Sutep Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Jung-Jr Ye et al.
BMC INFECTIOUS DISEASES (2016)
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study
Aristine Cheng et al.
CRITICAL CARE MEDICINE (2015)
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolates in the Gulf Cooperation Council States: Dominance of OXA-23-Type Producers
Hosam M. Zowawi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia
Gul Ruhsar Yilmaz et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Huang-Shen Lin et al.
INFECTIOUS DISEASES (2015)
Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii
Fatih Temocin et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2015)
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
A. Batirel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii
Yuan Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
G. Kalin et al.
INFECTION (2014)
When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing
Christopher D. Doern
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model
George Louis Drusano et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
Y. -T. Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development-Part 2: Introduction to Pharmacokinetic Modeling Methods
Dr Mould et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates
Aydin Deveci et al.
JOURNAL OF CHEMOTHERAPY (2012)
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
Michael N. Neely et al.
THERAPEUTIC DRUG MONITORING (2012)
Specific Labeling of Peptidoglycan Precursors as a Tool for Bacterial Cell Wall Studies
Vincent van Dam et al.
CHEMBIOCHEM (2009)
Pharmacokinetic issues for antibiotics in the critically ill patient
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore
Tze-Peng Lim et al.
JOURNAL OF ANTIBIOTICS (2009)
Antimicrobial Effects of Varied Combinations of Meropenem, Sulbactam, and Colistin on a Multidrug-Resistant Acinetobacter baumannii Isolate That Caused Meningitis and Bacteremia
Chen-Hsiang Lee et al.
MICROBIAL DRUG RESISTANCE (2008)
Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'
Lisa Saiman
PAEDIATRIC RESPIRATORY REVIEWS (2007)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Share Paper
